Filter
92
Text search:
Uppsala
Monitoring
Centre
Featured
Recommendations
8
New Publications
29
Language
Document type
No document type
42
Studies & Reports
22
Guidelines
13
Manuals
9
Strategic & Response Plan
3
Fact sheets
2
Resource Platforms
1
Countries / Regions
Ethiopia
3
Nepal
3
Kenya
3
Bangladesh
3
Global
3
Sierra Leone
2
Uganda
2
Philippines
2
Tanzania
2
Thailand
2
Rwanda
2
Namibia
2
Yemen
2
Western and Central Europe
2
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Zimbabwe
1
India
1
Zambia
1
Syria
1
Cambodia
1
Indonesia
1
South Africa
1
Malawi
1
Argentina
1
Ukraine
1
Madagascar
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Paraguay
1
Asia
1
Africa
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
33
Key Resources
7
Women & Child Health
5
Clinical Guidelines
4
Public Health
2
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
Pharmacy
18
AMR
9
COVID-19
6
TB
4
Malaria
4
Conflict
3
Caregiver
3
Planetary Health
3
Natural Hazards
2
Refugee
2
HIV
2
Mental Health
2
Disability
1
Ebola & Marburg
1
Polio
1
Rapid Response
1
Global Health Education
1
NTDs
1
Health Financing Toolbox
1
2.0 Rapid Response
1
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The report reviews progress with the task of planning and implementing measures necessary to secure a completely polio-free world. It also examines actions aimed at ensuring successful transfer of polio assets, innovations developed and lessons learned to countries’ public health programmes and ot
...
Framework for implementation.
The END TB Strategy.
This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes.
The aim of this guidance is to suppo
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
